Ipsen’s Phase II FALKON Trial Fails to Meet Primar...
Category : Clinical Trial Update 23 December 2025Ipsen has announced a setback in its rare disease pipeline. The company will discontinue the pivotal...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Emcure Launches Poviztra: A New Semaglutide Option...
Category : Clinical Trial Update 23 December 2025India’s obesity burden is rising fast. Emcure Pharmaceuticals is stepping in with a new treatm...
GC Biopharma Secures South Korea IND Approval for...
Category : Clinical Trial Update 23 December 2025GC Biopharma has cleared an important regulatory milestone in South Korea’s mRNA vaccine push....
Indian Pharma Backs US FDA’s New Safety Reporting...
Category : Approval/Launch 22 December 2025Indian pharmaceutical companies have welcomed the US FDA’s latest guidance on safety reporting...
Thermo Fisher Launches Global Real-World Registry...
Category : Approval/Launch 22 December 2025Thermo Fisher Scientific has enrolled the first patient in its new PPD CorEvitas Alzheimer’s D...
Latest Newsletter Post
-
GC Biopharma Secures South Korea IN..
23 December 2025
-
Emcure Launches Poviztra: A New Sem..
23 December 2025
-
Ipsen’s Phase II FALKON Trial Fails..
23 December 2025
-
Thermo Fisher Launches Global Real-..
22 December 2025
-
Indian Pharma Backs US FDA’s New Sa..
22 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com